38 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Disease in HIV-AIDS ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Microbial Etiology of Acute Pharyngitis - IDSA
Bacterial
 • Group A streptococcus - Pharyngotonsillitis, scarlet fever
 •
Pharyngitis - IDSA ... Primary acute HIV ... #diagnosis #differential ... #causes #bacteria ... #microbiology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Antibiotic Options for Treating MRSA Infections

PO: Doxycycline, Clindamycin, TMP-SMX, Linezolid
IV: Linezolid, Vancomycin, Ceftaroline, Daptomycin, Tigecycline

By Dr.
TMP-SMX, Linezolid IV ... SatyaPatelMD and Casey ... aureus #staph #pharmacology ... #management #microbiology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Infections in HIV-AIDS ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology